Table 4.
Comparison of complications between the two groups n (%)
|
PAD (n = 93) |
Non-PAD (n = 130) |
P value1 | |||||
| EPLBD + ES (n = 59) | EPLBD - ES (n = 34) | P value | EPLBD + ES (n = 73) | EPLBD - ES (n = 57) | P value | ||
| Pancreatitis | 2 (3.4) | 5 (14.7) | 0.095 | 7 (9.6) | 5 (8.8) | 0.873 | 0.809 |
| Perforation | 0 (0.0) | 0 (0.0) | NA | 0 (0.0) | 1 (1.8) | 0.438 | 1.000 |
| Bleeding | 2 (3.4) | 3 (8.8) | 0.351 | 7 (9.6) | 4 (7.0) | 0.601 | 0.548 |
| Major | 0 (0.0) | 0 (0.0) | 1 (1.4) | 0 (0.0) | |||
| Minor | 2 (13.4) | 3 (8.8) | 6 (8.2) | 4 (7.0) | |||
| Hyperamylasemia | 4 (6.8) | 5 (14.7) | 0.279 | 15 (20.5) | 6 (10.5) | 0.123 | 0.232 |
| Mortality | 0 (0.0) | 0 (0.0) | NA | 1 (1.4) | 1 (1.8) | 1.000 | 0.230 |
1
Comparison of the periampullary diverticula (PAD) and non-PAD groups. EPLBD: Endoscopic papillary large balloon dilation; ES: Endoscopic sphincterotomy; EPLBD + ES: Endoscopic papillary large balloon dilation with limited ES; EPLBD - ES: Endoscopic papillary large balloon dilation without ES; NA: Not applicable.